Coronavirus: Third jab boosts Omicron antibodies ‘significantly’, AstraZeneca study finds

British pharmaceutical giant AstraZeneca said Thursday that a third, or “booster”, dose of its Covid-19 vaccine Vaxzevria “significantly” lifted antibody levels against the Omicron strain in a laboratory study.“Vaxzevria significantly boosted levels of antibodies against the Omicron Sars-CoV-2 variant (B. 1.1.529) following a third dose booster,” the company announced in a statement citing the study.“The third dose booster vaccination neutralised the Omicron variant to levels that were broadly…

Read the original article at South China Morning Post